Retinal breaks due to intravitreal ocriplasmin
Ruwan A Silva, Darius M Moshfeghi, Theodore Leng Byers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, CA, USA Abstract: Ocriplasmin represents a new treatment option for numerous vitreoretinopathies involving an abnormal vitreomacular interface. While the drug may c...
Guardado en:
Autores principales: | Silva RA, Moshfeghi DM, Leng T |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3f1d3110abfc4a79a69b6a8a3353c680 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Lowered intraocular pressure in a glaucoma patient after intravitreal injection of ocriplasmin
por: McClintock M, et al.
Publicado: (2015) -
Case of retinal detachment due to retinal break splitting macula vertically in a patient with cognitive disorder
por: Yamamoto S, et al.
Publicado: (2011) -
Profile of ocriplasmin and its potential in the treatment of vitreomacular adhesion
por: Stefanini FR, et al.
Publicado: (2014) -
Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results
por: Demir M, et al.
Publicado: (2011) -
Retrospective Study of Ellipsoid Zone Integrity Following Treatment with Intravitreal Ocriplasmin (OZONE Study)
por: Drenser KA, et al.
Publicado: (2021)